NEW YORK, June 24, 2022 /PRNewswire/ — Jakubowitz Law announces that a securities fraud class action lawsuit has been filed on behalf of shareholders of CareDx, Inc. (NASDAQ: CDNA).
To receive updates on the trial, complete the form:
This lawsuit is on behalf of all persons or entities who have purchased common stock of CareDx between February 24, 2021and May 5, 2022.
Shareholders interested in acting as lead plaintiff representing the group of aggrieved shareholders have up to July 22, 2022 seize the tribunal. Your ability to participate in any collection does not require you to serve as the lead plaintiff.
According to a filed complaint, CareDx, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) the defendants engaged in a variety of improper and illegal schemes to inflate revenue and demand for testing services, including pushing a surveillance protocol through inaccurate marketing materials, offering outlandish inducements or bribes to doctors and other providers, and inappropriately bundling expensive testing services with d other blood tests as part of the company’s RemoTraC service for remote and home blood sampling; (2) these practices, and others, have subjected CareDx to undisclosed risk of regulatory scrutiny; (3) these practices artificially inflated the Company’s reported testing services revenues throughout the Class Period; and (4) therefore, defendants’ positive statements about the Company’s business, operations and prospects were materially false and misleading and/or lacked reasonable basis at all relevant times.
The Jakubowitz Act is vigorous in its pursuit of justice for shareholders who have been victims of securities fraud. Lawyer advertisement. Prior results do not guarantee similar results.
1140 Avenue of the Americas
New York, New York 10036
Such. : (212) 867-4490
Fax : (212) 537-5887
SOURCE Jakubowitz’s Law